Next Article in Journal
Titanium Dioxide Solar Photocatalytic Microbial Inactivation Assessment Utilizing Viability Tests and a Novel Triplex qPCR Assay for Nucleic Acid Degradation Determination
Previous Article in Journal
Aptamer-Based Biosensors for Rapid Detection and Early Warning of Food Contaminants: From Selection to Field Applications
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 30
Issue 22
10.3390/molecules30224331
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Ultrasound-Assisted Extraction: Unlocking the Antibacterial Potential of Coptis chinensis Franch. Against ESBL-Producing Enterobacterales

by
Ching Ching Hui
1,
Fred Wang Fat Lee
1,
Wesley Chin Ho Lung
1,
Kai Chung Fan
1,
Ivan Tak Fai Wong
2,
Gilman Kit Hang Siu
2,
Yeuk Lung Chow
3,
Ping Lung Chan
1,
Siu-Mui Ng
1,
Ling Shi
1,
Sai Wang Seto
4,5,
Franklin Wang Ngai Chow
2,6,* and
Emily Wan Ting Tam
1,*
1
School of Science and Technology, Hong Kong Metropolitan University, Ho Man Tin, Kowloon, Hong Kong SAR, China
2
Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China
3
School of Nursing and Health Sciences, Hong Kong Metropolitan University, Ho Man Tin, Kowloon, Hong Kong SAR, China
4
School of Biomedical Sciences, The University of Western Australia, Perth, WA 6009, Australia
5
NICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia
6
Research Centre for Chinese Medicine Innovation, The Hong Kong Polytechnic University, Hong Kong SAR, China
*
Authors to whom correspondence should be addressed.
Molecules 2025, 30(22), 4331; https://doi.org/10.3390/molecules30224331
Submission received: 15 September 2025 / Revised: 23 October 2025 / Accepted: 3 November 2025 / Published: 7 November 2025
(This article belongs to the Special Issue Extraction, Chromatography, and Mass Spectrometry Analysis of Food and Plant Biomolecules)
Browse Figures
Versions Notes

Abstract

The global rise of multidrug-resistant Extended Spectrum β-Lactamase Producing-Enterobacterales (ESBL-PE) poses a critical threat to public health, driving the urgent need for alternative therapeutic approaches. This study evaluates the antimicrobial properties of 20 Chinese medicinal herbs against 14 ESBL-PE strains from seven bacterial species, utilizing three extraction methods: traditional water decoction, 80% ethanol maceration, and 50% ethanol with ultrasound-assisted extraction (UAE). Among the herbs tested, Coptis chinensis Franch. demonstrated the most potent anti-ESBL-PE activity, effectively inhibiting multiple strains, including Escherichia coli, Klebsiella pneumoniae, Hafnia alvei, Citrobacter freundii and Proteus hauseri. C. chinensis extracts obtained via UAE exhibited superior antibacterial activity to the other two extraction methods, attributed to enhanced extraction efficiency and improved bioactive compound yields. Specifically, UAE increased the extraction yield of alkaloids in C. chinensis by 80.9%, compared to the ethanol maceration method, and the increase in berberine, the key antimicrobial compound, was 75.4%. Berberine demonstrated significant antibacterial effects against ESBL-PE strains, while other phytochemicals in C. chinensis extracts have an additional effect with berberine, further amplifying the overall antimicrobial activity. These findings highlight that the UAE is a promising method for enhancing the therapeutic potential of C. chinensis and other Chinese medicinal herbs against multidrug-resistant bacteria.

1. Introduction

Enterobacterales, an order of Gram-negative bacteria, includes several well-known pathogens such as Salmonella, Klebsiella, Escherichia coli, Enterobacter, and Shigella [1]. These genera predominantly inhabit the intestinal tract of humans and animals, and some members are also found in the environment [2]. Extended-Spectrum β-Lactamase-Producing-Enterobacterales (ESBL-PE) produces an enzyme known as extended-spectrum beta-lactamase (ESBL) that degrades commonly used antibiotics, rendering them ineffective for treating infections [3]. The widespread use of third- and fourth-generation cephalosporins has driven the emergence of ESBL-PE [4]. The global spread of ESBL-PE has escalated significantly, posing a critical threat to public health. ESBL enzymes can be easily transmitted among Enterobacterales members via plasmid-mediated gene transfer. This mechanism also facilitates the spread of resistance to other commonly used antibiotics, such as aminoglycosides, fluoroquinolones, and sulphonamides, contributing to the rise of multidrug-resistant ESBL-PE [5,6]. Consequently, patients often require last-resort antibiotics, such as carbapenems, to treat infections caused by multidrug-resistant bacteria [7,8]. However, the increased use of carbapenem has led to a rapid rise in carbapenem-resistant Enterobacterales [9]. This alarming trend underscores the urgent need for effective strategies to prevent the emergence of multidrug-resistant bacteria and to discover novel anti-ESBL-PE agents.
The development of new antimicrobial drugs is a complex, time-intensive, and expensive process. It often requires more than 7 years to secure regulatory approval, and the clinical approval rate is less than 20% [10]. Because of this slow process and the urgent need for an effective method to prevent the emergence of multidrug-resistant bacteria, scientists have increasingly turned to Chinese medicinal herbs as a promising alternative. These herbs and their active ingredients have demonstrated multiple antibacterial and bactericidal properties [11,12,13,14]. They are effective against antibiotic-resistant bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) [15,16,17,18]. The antibacterial and bactericidal properties of Chinese medicinal herbs are primarily achieved through mechanisms such as inhibiting biofilm formation in drug-resistant bacteria, suppressing the efflux pump system, eliminating resistant plasmids, and altering bacterial permeability [19]. For instance, extracts from Reynoutria japonica Houtt. have been shown to damage the cell walls and cytoplasmic membranes of nosocomial drug-resistant bacteria such as Staphylococcus aureus, Pseudomonas aeruginosa and Acinetobacter baumannii [13]. Similarly, extracts from Sophora moorcroftiana (Benth.) Baker exhibit antibacterial properties by suppressing the efflux pump system of drug-resistant Staphylococcus aureus [20]. These findings suggest that Chinese medicinal herbs could serve as viable alternatives or adjuncts to conventional antibiotics. Compared to conventional antibiotics, Chinese medicinal herbs offer several advantages, including more abundant resources, easier availability, reduced likelihood of drug resistance, and a higher diversity of active ingredients [21]. Additionally, they exhibit fewer side effects and target a broader range of mechanisms [22].
The main active ingredients in traditional Chinese herbs that exhibited antimicrobial properties include flavonoids, alkaloids, phenols, quinones, and tannins. These phytochemicals have demonstrated synergistic effects with various antibiotics in treating drug-resistant bacterial infections [21]. The type and quantity of bioactive compounds isolated from Chinese medicinal herbs depend on the extraction methods, affecting their antibacterial efficacy and antimicrobial potency. Various forms of herbal extracts have been developed over the long history of Chinese medicinal herbs. Among these, decoction in water and maceration in alcohol are the two most common methods due to their simple application, easy preparation, low cost, and proven medicinal efficacy [23,24]. More recently, ultrasound-assisted extraction (UAE) has emerged as a powerful technique for enhancing the extraction of bioactive compounds due to its superior efficiency and extraction capacity [25,26,27,28]. UAE offers several advantages, including shorter extraction times, reduced solvent usage, lower energy consumption, operation at low temperatures, increased cost-effectiveness, and higher environmental sustainability. While UAE has been shown to significantly enhance the antioxidant activity of extracts from various medicinal herbs compared to traditional methods such as water decoction and alcohol maceration [29,30], its impact on the antibacterial properties of herb extracts remains underexplored. The efficacy and types of bioactive compounds extracted by UAE may also vary among different Chinese medicinal herbs. This study aims to address these gaps by investigating the application of UAE in extracting bioactive compounds from Chinese medicinal herbs with potential antibacterial activity against multidrug-resistant bacteria. Unlike previous research, which primarily focuses on UAE’s role in extracting biomolecules for anti-cancer or antioxidant purposes, this work emphasizes its potential in combating antimicrobial resistance. We hypothesize that UAE may extract a greater quantity of bioactive compounds from Chinese medicinal herbs, resulting in higher antibacterial efficacy compared to conventional extraction methods, though the results may vary depending on the specific herb. This study will compare the efficacy of various extraction methods, identify the most potent herbal extracts, and determine their primary active anti-ESBL-PE compounds. The work will provide scientific information for the development of Chinese medicinal herbs as potential therapeutic agents to combat multidrug-resistant bacteria.

2. Results

2.1. The Antibiotic-Resistant Profile of ESBL-PE Strains

This study included 14 multidrug-resistant ESBL-PE strains (B1–B14) isolated from food samples, comprising three E. coli (B1–B3), four Klebsiella pneumoniae (B4–B7), two Hafnia alvei (B8–B9), two Citrobacter freundii (B10–B11), one Citrobacter braakii (B12), one Proteus hauseri (B13), and one Enterobacter cloacae (B14) (Table 1). Species identification was confirmed using Matrix-Assisted Laser Desorption Ionization Time-Of-Flight Mass Spectrometry (MALDI-TOF MS), with all strains achieving a score of ≥2.0, indicating successful and reliable identification. Antimicrobial susceptibility testing using a panel of 16 antibiotics revealed that all strains were multidrug-resistant, exhibiting resistance to three or more antibiotic classes. ESBL production was confirmed using the double disc synergy test and further validated by whole-genome sequencing, which identified at least one beta-lactamase resistance gene in each isolate (Table 2). Notably, 9 out of the 14 ESBL-PE strains harbored multiple beta-lactamase resistance genes. All beta-lactamase resistant genes identified in these strains belonged to Ambler classes A, C, or D [31]. Among these, only one class D beta-lactamase resistance gene, blaOXA, was detected in K. pneumoniae (B6). All other beta-lactamase resistance genes belonged to classes A or C. Furthermore, all ESBL strains were resistant to ampicillin and cefotaxime but remained susceptible to meropenem and doripenem (Table 2). Multiple efflux pump genes were also detected in 10 strains, including all strains of E. coli, K. pneumoniae, C. freundii, and E. cloacae. The presence of these efflux pump genes suggests that efflux-mediated mechanisms may contribute to the multidrug resistance observed in these strains. In contrast, no efflux pump genes were identified in H. alvei, C. braakii, or P. hauseri strains. Their multidrug resistance profiles may instead be attributed to other mechanisms.

2.2. UAE Extracts of Coptis chinensis Franch. Exhibited the Most Potent Anti-ESBL-PE Activity

2.2.1. Bacterial Growth Inhibition

Disc diffusion results revealed that 6 out of 20 tested Chinese medicinal herbs, namely Lithospermum erythrorhizon Siebold & Zucc., Sarcandra glabra (Thunb.) Nakai, Scutellaria baicalensis Georgi, C. chinensis Franch., Prunella vulgaris L., and Magnolia officinalis Rehder & E.H.Wilson, demonstrated broad-spectrum anti-ESBL-PE activity across all three extraction methods. However, their efficacy varied depending on the herbs and the extraction method used (Table 3). The remaining 14 herbs showed no bacterial growth inhibition effects. Among the extraction methods, the water decoction extracts of L. erythrorhizon, S. glabra, and M. officinalis exhibited the highest antibacterial activity, in terms of both the inhibition zone diameter (IZD) and the number of susceptible ESBL-PE strains. Specifically, these water decoction extracts showed antibacterial effects against seven, six, and five ESBL-PE strains, respectively. Conversely, the ethanol with UAE extracts of C. chinensis and P. vulgaris outperformed the water decoction and ethanol maceration extracts, displaying the highest antibacterial activity, affecting eight and six ESBL-PE strains, respectively. For S. baicalensis, both the water decoction and ethanol with UAE extracts exhibited comparable antimicrobial activity, each inhibiting six ESBL-PE strains. These findings indicate that there is no universal extraction method that consistently enhances the antibacterial activity of all herbal extracts, and the effectiveness is herb-specific. However, when comparing the two ethanol-based methods (ethanol maceration and ethanol with UAE), the UAE method consistently demonstrated higher antibacterial activity across all six herbs, as measured by both IZD and the number of susceptible ESBL-PE strains. Notably, among all the herb extracts, the UAE extract of C. chinensis exhibited the strongest anti-ESBL-PE activity, with an IZD ranging from 6.95 ± 0.10 mm to 13.38 ± 0.22 mm against eight ESBL-PE strains, followed by L. erythrorhizon, with an IZD ranging from 7.29 ± 0.04 mm to 9.49 ± 0.09 mm against seven ESBL-PE strains. Importantly, C. chinensis was the only herb that demonstrated antimicrobial activity against ESBL-producing E. coli (Table 3).

2.2.2. Determination of Minimum Inhibitory Concentration (MIC) of Herb Extracts

To further evaluate the anti-ESBL-PE activities of the six Chinese medicinal herbs L. erythrorhizon, S. glabra, M. officinalis, C. chinensis, P. vulgaris and S. baicalensis that demonstrated antibacterial effects in the disc diffusion assay, the MIC values of all their extracts were determined against ESBL-PE strains. Six strains, randomly selected from species that showed susceptibility in the disc diffusion assay, included E. coli (B2), K. pneumoniae (B6), H. alvei (B8), C. freundii (B10), C. braakii (B12), and P. hauseri (B13). The MIC results revealed that all herb extracts exhibited antibacterial effects against the six selected ESBL-PE strains, with MIC values ranging from 0.78125 to 25 mg/mL. However, the ethanol maceration extract of S. glabra did not show any anti-ESBL-PE activity against the E. coli B2 strain within the tested concentration range (Table 4). When comparing the two ethanol-based extraction methods (ethanol maceration and UAE), the UAE method generally yielded lower MIC values, aligning with the disc diffusion assay results and indicating that UAE is a more effective extraction method than traditional maceration for most herbs. However, for S. baicalensis, the MIC values obtained using UAE were similar to those from ethanol maceration, indicating that the difference between the two methods for S. glabra is minimal. When comparing the antibacterial effects of water decoction and UAE extracts from the same herb, the MIC values against all ESBL-PE species were either identical or differed by one-fold. Among the six herbs, C. chinensis exhibited the most potent antimicrobial effect against ESBL-producing E. coli, with MIC values of 1.5625 mg/mL for the UAE extract and 3.125 mg/mL for the water decoction extract. In contrast, the other five herbs (L. erythrorhizon, S. glabra, S. baicalensis, P. vulgaris, and M. officinalis) showed significantly higher MIC values (12.5–25 mg/mL) (Table 4). Furthermore, the UAE extract of C. chinensis exhibited the strongest overall inhibitory effect on ESBL-PE strains, with MIC values ranging from 1.5625 to 3.125 mg/mL. The finding indicates that C. chinensis has the highest potential for development as an anti-ESBL-PE agent. Interestingly, some herb extracts that did not exhibit antibacterial effects against certain ESBL strains in the disc diffusion assay (Table 3) showed activity in the MIC test (Table 4). This discrepancy suggests the disc diffusion assay has certain limitations, such as diffusion constraints, which can affect the detection of antibacterial activity.

2.2.3. UAE Extracts of C. chinensis Contained the Highest Alkaloid Content

Since C. chinensis displayed the most potent antimicrobial activities among all 20 herb extracts, the differences in phytochemical compositions of C. chinensis extracted by different methods were investigated using HPLC-UV analysis (Figure 1). The results revealed that the seven most abundant alkaloids in the three C. chinensis extracts were berberine, epiberberine, palmatine, coptisine, jatrorrhizine, columbamine, and groenlandicine, listed in descending order of abundance (Figure 2 and Table 5). These alkaloids constituted 42.4%, 29.9% and 54.1% of the total content in the water decoction, ethanol maceration and UAE extracts, respectively. Among these alkaloids, berberine was the most abundant compound across all C. chinensis extracts, accounting for 17.9%, 13.4%, and 23.5% of the total content in the water decoction, ethanol maceration, and UAE extracts, respectively (Table 5). Notably, the UAE method consistently extracted higher levels of each of the seven alkaloids compared to the other two methods, explaining why the UAE extracts of C. chinensis exhibited the strongest antimicrobial activity (Table 4). When comparing alkaloid extraction yields between the ethanol maceration method and the UAE methods, UAE was found to significantly enhance the extraction yield of bioactive alkaloids in C. chinensis by 80.9% compared to the ethanol maceration method. Specifically, the extraction yield of berberine was increased by 75.4%, highlighting the efficiency of UAE in maximizing the recovery of key antimicrobial compounds. The antimicrobial efficacy of C. chinensis might closely correlate with the abundance of alkaloid content in the extracts. Specifically, the higher concentration of alkaloids, particularly berberine, in the UAE extracts may contribute to their superior antibacterial effects against ESBL-PE strains.

2.2.4. The Antibacterial Activity of C. chinensis Is Predominantly Attributed to Berberine, with Additional Contributions from Other Phytochemicals

To investigate whether berberine is the primary antibacterial compound in the C. chinensis UAE extracts against ESBL-PE strains, the MIC values of berberine alone were compared to those of the C. chinensis extracts. Table 6 showed that the MIC value of berberine alone was 0.75 mg/mL, which was lower than the MIC value of the C. chinensis extracts against ESBL-producing E. coli (1.5625 mg/mL). However, when the equivalent concentration of berberine in the C. chinensis extract was calculated, the MIC value of the equivalent berberine in the C. chinensis extracts was 0.368 mg/mL, which was significantly lower than that of berberine alone. Similar results were observed for other ESBL-PE strains, including K. pneumoniae, H. alvei, C. freundii, C. braakii, and P. hauseri (Table 6). These findings suggest that, while berberine is the primary antibacterial agent in C. chinensis, other phytochemicals present in the extracts exert a synergistic or additional effect on berberine, significantly enhancing the overall antibacterial activity against ESBL-PE strains.

3. Discussion

The global rise of multidrug-resistant ESBL-PE has become a critical public health concern, necessitating the exploration of alternative therapeutic strategies. This study identified 14 multidrug-resistant ESBL-PE strains from food samples, each confirmed as multidrug-resistant and exhibiting resistance to multiple antibiotic classes, including key cephalosporins such as ampicillin and cefotaxime (Table 1). These findings reinforce evidence that food can serve as a significant reservoir for antibiotic resistance genes with zoonotic and clinical implications [32,33,34]. In addition to ESBL production, most isolates carried efflux pump genes, indicating multifactorial resistance mechanisms that involve both enzymatic degradation and active efflux. The coexistence of these pathways likely facilitates survival against diverse antibiotics and may complicate treatment options for ESBL-PE infections. Given this resistance landscape, the exploration of alternative antimicrobial agents is timely and necessary.
Traditional Chinese medicinal herbs, with well-documented pharmacological activities, have garnered particular interest due to their rich and diverse phytochemical content, including flavonoids, tannins, alkaloids, phenolics, sulfur compounds, and terpenoids [22,35,36,37,38,39,40]. However, the efficacy of these herbs depends on both the quality and quantity of bioactive compounds, which in turn are affected by the types of herbs and extraction methodologies. Traditional decoction, which involves boiling herbs, is supported by substantial clinical evidence for its efficacy [41]. This method is particularly effective at extracting water-soluble compounds, such as saponins, flavonoids and polyphenols, which are key bioactive components with antimicrobial properties [42,43]. Additionally, the boiling process can promote the formation of new compounds with synergistic effects [41]. However, prolonged exposure to high temperatures may degrade volatile and heat-sensitive molecules. Maceration, another widely used method for preparing herbal medicines, involves soaking herbal material in ethanol at an appropriate concentration at room temperature for an extended period. This process softens and breaks down plant cell walls, facilitating the release of soluble bioactive metabolites. The absence of heat helps preserve thermolabile and volatile compounds [44]. Ethanol maceration is particularly effective at extracting hydrophilic compounds such as alkaloids, flavonol, tannins, and terpenoids, many of which exhibit antimicrobial properties [45,46]. However, this method has limitations, including lengthy extraction times and relatively low extraction efficacy. UAE has emerged as a superior alternative for extracting active compounds from medicinal plants. UAE enhances solvent penetration into plant cells and improves mass transfer, accelerating the release of bioactive compounds [28,47].
In this study, several Chinese medicinal herbs, including L. erythrorhizon, S. glabra, M. officinalis, C. chinensis, P. vulgaris, and S. baicalensis, exhibited broad-spectrum anti-ESBL-PE activity across all extraction methods, as demonstrated by disc diffusion tests and MIC assays. The antimicrobial compounds in these herbs probably derive from distinct phytochemical classes. The naphthoquinone shikonin in L. erythrorhizon, terpenoids and organic acids in S. glabra, potent flavonoids in S. baicalensis, alkaloids (especially berberine) in C. chinensis, triterpenoids in P. vulgaris, and the lignan honokiol in M. officinalis, have demonstrated antibacterial and wound-healing properties in previous studies [48,49,50,51,52,53,54,55]. Notably, among the extraction methods, UAE consistently exhibited superior antibacterial activity compared to ethanol maceration across all six herbs. The enhanced efficiency of UAE is likely due to its ability to accelerate the disruption of plant cell walls, thereby facilitating the release of bioactive compounds [47]. This method significantly increased the extraction yield of bioactive compounds across diverse phytochemical groups, including naphthoquinones, terpenoids, flavonoids, alkaloids, triterpenoids, and lignans, all of which are known for their antimicrobial properties. HPLC-UV analysis further validated that UAE significantly increases the extraction yield of bioactive alkaloids in C. chinensis by 80.9% compared to the traditional ethanol maceration method. Specifically, the extraction yield of berberine was increased by 75.4%, highlighting the effectiveness of UAE in maximizing the recovery of key antimicrobial compounds.
Among the herbs tested, C. chinensis emerged as the most potent against ESBL-PE, demonstrating the broadest antibacterial effects, as evidenced by IZD values, MIC values, and the number of ESBL-PE strains inhibited. The UAE extract of C. chinensis effectively inhibited various ESBL-PE strains, including E. coli, K. pneumoniae, H. alvei, C. freundii, and P. hauseri. Berberine, an isoquinoline alkaloid identified in C. chinensis, is a key active ingredient with well-documented antibacterial, antiviral, and anti-inflammatory properties [56]. It has been traditionally used to treat intestinal infections such as acute gastroenteritis, cholera, and bacillary dysentery [57,58]. Interestingly, the study revealed that while berberine alone exhibits antimicrobial activity, the whole C. chinensis extract demonstrated even greater efficacy, indicating potential synergistic or additive interactions among co-extracted phytochemicals. This synergy likely enhances cell membrane permeability, disrupts efflux mechanisms, or interferes with other bacterial resistance pathways. Further investigation is needed to identify these synergistic phytochemicals, which could aid in the development of anti-ESBL-PE agents capable of combating multidrug-resistant bacteria.
This study provides valuable insight into the relationship between extraction methodology and antimicrobial efficacy, suggesting that UAE is a promising technique to maximize the therapeutic potential of Chinese medicinal herbs, particularly C. chinensis, against multidrug-resistant ESBL-PE. These findings support the inclusion of UAE-extracted C. chinensis as a candidate for further development. Future investigations should focus on optimizing UAE parameters, characterizing synergistic phytochemicals within C. chinensis, and validating efficacy through in vivo trials. Additionally, investigating the molecular pathways targeted by these alkaloids, such as their effects on bacterial cell walls, efflux pump systems, biofilm formation, and plasmid-mediated resistance, will be crucial. Mechanistic studies using transcriptomics could provide deeper insights into how these compounds disrupt bacterial resistance mechanisms. Overall, the findings highlight the potential of UAE to advance natural alternatives to traditional antibiotics, presenting a promising avenue for addressing the escalating challenge of ESBL-PE infections.

4. Materials and Methods

4.1. ESBL-PE Strains

Multidrug-resistant ESBL-PE strains were isolated from food samples, including pork, chicken, beef, sashimi, and vegetable, purchased from the Hong Kong market in 2022. All food samples were stored at 4 °C immediately after purchase and processed on the same day. A 25 g portion of each sample was homogenized in a stomacher (Seward stomacher 400, Worthing, UK) with a 1:10 dilution of phosphate-buffered saline (PBS). The homogenized samples were plated onto MacConkey Agar (MCA) and Violet Red Bile Glucose Agar (VRBGA) (Merck, Darmstadt, Germany). Plates were incubated aerobically at 37 °C for 24 h. Bacterial colonies from plates showing growth were sub-cultured onto nutrient agar plates and incubated at 37 °C for 24 h.
The identification of Enterbacterales strains was carried out by using MALDI-TOF MS with the MALDI Biotyper Sirius system (Bruker, Billerica, MA, USA), following the methodology described in our previous publication [59]. Briefly, a bacterial colony was mixed with 1 µL of matrix solution and allowed to dry on a stainless-steel target plate. Identification was then conducted using MALDI-TOF MS, and the resulting spectra were analyzed and compared against the Bruker Biotyper database using the MBT Compass Library (version 12.0.0.0). The presence of ESBLs was initially screened through antimicrobial susceptibility testing and subsequently confirmed by molecular profiling. Antimicrobial susceptibility testing was conducted using a panel of antibiotics, including ampicillin, cefepime, cefotaxime, cefoxitin, ceftazidime, ceftriaxone, chloramphenicol, ciprofloxacin, colistin, gentamicin, imipenem, meropenem, nalidixic acid, tetracycline, co-trimoxazole, and doripenem (Sigma-Aldrich, St. Louis, MO, USA). The ESBL phenotype was confirmed using the double-disc synergy test in accordance with the CLSI guidelines [60]. Isolates exhibiting resistance to three or more antibiotic classes were classified as multidrug-resistant strains [61]. To further characterize the strains, whole-genome sequencing was performed to identify ESBL-resistant genes and efflux pump genes. Genomic DNA was extracted using the QIAamp BiOstic Bacteremia DNA Kit (Qiagen, Hilden, Germany), and DNA library preparation was conducted following the SQK-RBK110.96 protocol (Oxford Nanopore Technologies, Oxford, UK). The pooled barcoded library was purified using AMPure XP beads (Beckman Coulter Inc., Brea, CA, USA). After adaptor ligation, the library pool was loaded onto R9.4.1 flow cells and sequenced on a Nanopore GridION sequencer (Oxford Nanopore Technologies) for 48 h using the super-accurate (SUP) base-calling mode. A minimum sequencing depth of 50× coverage was achieved, and high-quality sequence reads were retained after filtering. Genome assembly was performed using Dragonflye (v1.0.13), and antimicrobial resistance genes, including efflux pump genes, were identified using AMRFinderPlus (v3.10.30). Fourteen multidrug-resistant ESBL-PE strains (Table 6) were finally selected as representative Enterobacterales for this study based on their prevalence in the community, clinical significance, and multidrug-resistant profiles.

4.2. Chinese Medicinal Herbs

Twenty different types of Chinese medicinal herbs were selected based on their traditional antibacterial pharmacological functions and historical usage for evaluation of their anti-ESBL-PE properties (Table 7). The herbs were sourced from Tsang Fook Kee Medicine Company Limited, a retail shop in Hong Kong, with their origins traced to various cities across China. The authenticity of the herbs was verified by Chinese Medicinal Pharmacist Dr. Yeuk-Lung Chow.

4.3. Extraction of Chinese Medicinal Herbs

The dried herbs were coarsely ground using a blender, and each herb was subjected to three different extraction methods: water decoction, 80% ethanol maceration, and 50% ethanol extraction with UAE [63,64]. For the decoction extraction, 25 g of ground herbs were heated with 250 mL of distilled water for 25 min at 100 °C with stirring. The decocted solution was filtered immediately after cooling to room temperature. For the 80% ethanol maceration, 25 g of ground herbs were mixed with 250 mL of 80% ethanol and agitated for 72 h. The maceration process was repeated once, and the extracts from both rounds were combined. For the UAE method, 25 g of ground herbs were mixed with 250 mL of 50% ethanol and subjected to ultrasonic irradiation at 60 °C for 50 min with 100 W power in an ultrasonic bath (Bransonic M3800H-E, Brookfield, CT, USA). All extracts were filtered through a 0.45 μm microporous filter membrane. After filtration, the extracts were evaporated under vacuum at 50 °C using a rotary evaporator. The extracts were re-suspended in deionized water, freeze-dried and stored in an electronic desiccator until further experimentation. Freeze-drying was essential to quantify the concentration required for performing the disc diffusion test and MIC test.

4.4. Determination of Inhibition Zone of Herb Extracts by Disc Diffusion Methodology

Each herb extract was evaluated for anti-ESBL-PE activity against the 14 different ESBL-PE strains using the disc diffusion method, with reference to CLSI guidelines [60]. Briefly, bacterial culture was adjusted to a 0.5 McFarland standard and evenly spread across Mueller–Hinton agar (MHA) plates using sterile swabs. Herb extracts were dissolved in Mueller–Hinton broth (MHB) containing 5% DMSO(aq) and filtered through a 0.22 µm syringe filter. A 6 mm blank disc was soaked with 20 µL of herb extract, resulting in a final concentration of 8 mg of herb extract per disc and placed on the MHA surface. Each test plate comprised eight discs, including one positive control, one negative control, and six discs treated with herb extracts. The positive control was a commercial gentamicin 10 µg antibiotic disc, while the negative control was a disc containing 5% DMSO(aq). Plates were incubated at 37 °C for 18–22 h. The antibacterial activity of the Chinese medicinal herbs was assessed by measuring the inhibition zone diameter (IZD) around the discs using a caliper. The assay was performed in triplicate.

4.5. Determination of the Minimum Inhibitory Concentration (MIC) of Herb Extracts and Berberine

The MICs of Chinese medicinal herb extracts and berberine (ChemFaces, Wuhan, China) against ESBL-PE strains were determined following the methodology described by Chassagne et al. (2019), in accordance with EUCAST and CLSI standards [60,63,65]. MIC testing was conducted using 96-well plates, with the final concentration of DMSO(aq) in each well kept below 5%. Herb extracts and berberine were tested at concentrations ranging from 0.39 to 25 mg/mL. The initial bacterial concentration in each test well, except for the negative control, was standardized to 1.5 × 106 CFU/mL. Negative control wells contained herb extract or berberine without bacterial inoculation, while positive control wells contained bacterial inoculation without herb extract or berberine. The plates were incubated at 37 °C for 18 h. MIC values were determined visually by assessing the lowest concentration of herb extract or berberine that inhibited visible bacterial growth. All tests were conducted in triplicate.

4.6. Detection and Quantification of Alkaloid Compounds in C. chinensis Extracts Using High-Performance Liquid Chromatography-Ultraviolet (HPLC-UV) Spectrophotometry

HPLC-UV analysis of C. chinensis extracts was performed based on a previously published method with minor modifications [66]. For each extract, 0.1 g of C. chinensis was mixed with 25 mL of a hydrochloric acid and methanol solution (1:100 v/v). The total weight of the mixture was recorded, and the sample was ultrasonicated for 30 min. After cooling, the mixture was reweighed, and any weight loss was replenished with the same hydrochloric acid and methanol solution. The solution was then filtered through a 0.45 μm syringe filter, and the filtrate was transferred into a 2 mL vial for chromatographic analysis.
Chromatographic analysis was performed using an Agilent 1290 Infinity UPLC System equipped with a diode array detector (DAD) (Agilent Technologies, Santa Clara, CA, USA) and an XBridge C18 chromatographic column (4.6 × 150 mm, 5 μm) (Waters, Wexford, Ireland). The column temperature was maintained at 25 °C. The mobile phase consisted of acetonitrile (A) and 0.03 mol/L ammonium acetate solution containing 0.1% triethylamine and 0.6% ammonium hydroxide (%v/v) (B). The gradient program was set as follows: 0–16 min, 10–22% A; 16–30 min, 22–24% A; 30–33 min, 24–100% A. The injection volume for each sample was 2 µL. The flow rate was set at 0.5 mL/min for the first 15 min, then increased to 1.0 mL/min. The detection wavelength was set at 270 nm. The detected phytochemical compounds were validated using different reference standards. All the solvents used in HPLC-UV detection were of analytical grade and were purchased from Sigma-Aldrich, USA. The reference standards of berberine, palmatine, coptisine, epiberberine, columbamine, jatrorrhizine, and groenlandicine were purchased from ChemFaces, China. Following chromatographic analysis, the yields of alkaloids in the CR extract were calculated using the following formula:
W e i g h t   o f   a l k a l o i d s   i n   C .   c h i n e n s i s   e x t r a c t   ( m g )   T o t a l   w e i g h t   o f   C .   c h i n e n s i s   e x t r a c t   ( m g ) × 100 %
To compare the alkaloid extraction yields between the ethanol maceration method and the UAE method, the following formula was applied:
%   t o t a l   a l k a l o i d s   c o n t e n t   i n   U A E   e x t r a c t   −   %   t o t a l   a l k a l o i d s   c o n t e n t   i n   m a c e r a t i o n   e x t r a c t     %   t o t a l   a l k a l o i d s   c o n t e n t   i n   m a c e r a t i o n   e x t r a c t × 100 %

Author Contributions

Conceptualization, E.W.T.T., C.C.H., and F.W.N.C.; methodology, E.W.T.T., F.W.N.C., and F.W.F.L.; validation, S.W.S., I.T.F.W., Y.L.C., and G.K.H.S.; formal analysis, C.C.H., K.C.F., and W.C.H.L.; investigation, F.W.F.L., Y.L.C., W.C.H.L., P.L.C., S.-M.N., L.S., and C.C.H.; resources, E.W.T.T., Y.L.C., and F.W.N.C.; data curation, I.T.F.W.; writing—original draft preparation, C.C.H. and E.W.T.T.; writing—review and editing, F.W.F.L., K.C.F., W.C.H.L., I.T.F.W., G.K.H.S., Y.L.C., P.L.C., S.-M.N., L.S., S.W.S., and F.W.N.C.; supervision, F.W.F.L., E.W.T.T., and F.W.N.C.; project administration, C.C.H.; funding acquisition, E.W.T.T., G.K.H.S., Y.L.C., and F.W.N.C. All authors have read and agreed to the published version of the manuscript.

Funding

The work described in this paper was funded by the Research Grants Council of the Hong Kong Special Administrative Region, China (UGC/FDS25(16)/P03/19) and Hong Kong Metropolitan University Research Grants (RD/2022/1.7) and (PFDS/2024/19).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The corresponding author will provide the data used in this study upon reasonable request.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
ESBL-PEExtended-Spectrum β-Lactamase-Producing-Enterobacterales
IZDinhibition zone diameter
MALDI-TOF MSMatrix-Assisted Laser Desorption Ionization Time-Of-Flight Mass Spectrometry
MICminimum inhibitory concentration
UAEultrasound-assisted extraction

References

  1. Janda, J.M.; Abbott, S.L. The Changing Face of the Family Enterobacteriaceae (Order: “Enterobacterales”): New Members, Taxonomic Issues, Geographic Expansion, and New Diseases and Disease Syndromes. Clin. Microbiol. Rev. 2021, 34, e00174-20. [Google Scholar] [CrossRef]
  2. Aidara-Kane, A.; Andremont, A.; Collignon, P. Antimicrobial resistance in the food chain and the AGISAR initiative. J. Infect. Public Health 2013, 6, 162–165. [Google Scholar] [CrossRef]
  3. Centers for Disease Control and Prevention. About ESBL-Producing Enterobacterales. 2024. Available online: https://www.cdc.gov/esbl-producing-enterobacterales/about/index.html#:~:text=ESBL%2Dproducing%20Enterobacterales%20can%20cause,or%20symptoms%2C%20known%20as%20colonization (accessed on 27 September 2024).
  4. Founou, L.L.; Founou, R.C.; Ntshobeni, N.; Govinden, U.; Bester, L.A.; Chenia, H.Y.; Djoko, C.F.; Essack, S.Y. Emergence and Spread of Extended Spectrum β-Lactamase Producing Enterobacteriaceae (ESBL-PE) in Pigs and Exposed Workers: A Multicentre Comparative Study between Cameroon and South Africa. Pathogens 2019, 8, 10. [Google Scholar] [CrossRef] [PubMed]
  5. Schwaber, M.J.; Navon-Venezia, S.; Schwartz, D.; Carmeli, Y. High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob. Agents Chemother. 2005, 49, 2137–2139. [Google Scholar] [CrossRef]
  6. Chandel, D.S.; Johnson, J.A.; Chaudhry, R.; Sharma, N.; Shinkre, N.; Parida, S.; Misra, P.R.; Panigrahi, P. Extended-spectrum beta-lactamase-producing Gram-negative bacteria causing neonatal sepsis in India in rural and urban settings. J. Med. Microbiol. 2011, 60 Pt 4, 500–507. [Google Scholar] [CrossRef]
  7. Paterson, D.L. Resistance in gram-negative bacteria: Enterobacteriaceae. Am. J. Med. 2006, 119 (Suppl. S1), S20–S70. [Google Scholar] [CrossRef]
  8. Paterson, D.L.; Ko, W.C.; Von Gottberg, A.; Casellas, J.M.; Mulazimoglu, L.; Klugman, K.P.; Bonomo, R.A.; Rice, L.B.; McCormack, J.G.; Yu, V.L. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: Implications for the clinical microbiology laboratory. J. Clin. Microbiol. 2001, 39, 2206–2212. [Google Scholar] [CrossRef]
  9. Walsh, T.R. Emerging carbapenemases: A global perspective. Int. J. Antimicrob. Agents 2010, 36 (Suppl. S3), S8–S14. [Google Scholar] [CrossRef] [PubMed]
  10. Asokan, G.V.; Ramadhan, T.; Ahmed, E.; Sanad, H. WHO Global Priority Pathogens List: A Bibliometric Analysis of Medline-PubMed for Knowledge Mobilization to Infection Prevention and Control Practices in Bahrain. Oman Med. J. 2019, 34, 184–193. [Google Scholar] [CrossRef]
  11. Wu, C.M.; Cao, J.L.; Zheng, M.H.; Ou, Y.; Zhang, L.; Zhu, X.Q.; Song, J.X. Effect and mechanism of andrographolide on the recovery of Pseudomonas aeruginosa susceptibility to several antibiotics. J. Int. Med. Res. 2008, 36, 178–186. [Google Scholar] [CrossRef] [PubMed]
  12. Ma, F.; Chen, Y.; Li, J.; Qing, H.P.; Bai, Y. Screening test for anti-Helicobacter pylori activity of traditional Chinese herbal medicines. World J. Gastroenterol. 2010, 16, 5629–5634. [Google Scholar] [CrossRef]
  13. Su, P.W.; Yang, C.H.; Yang, J.F.; Su, P.Y.; Chuang, L.Y. Antibacterial Activities and Antibacterial Mechanism of Polygonum cuspidatum Extracts against Nosocomial Drug-Resistant Pathogens. Molecules 2015, 20, 11119–11130. [Google Scholar] [CrossRef]
  14. Kwok, C.T.; Hu, Y.; Tsoi, B.; Wong, F.; Hau, P.; Tam, E.W.; Mok, D.K.; Kwan, Y.; Leung, G.P.; Lee, S.M.; et al. Medulla Tetrapanacis water extract ameliorates mastitis by suppressing bacterial internalization and inflammation via MAPKs signaling in vitro and in vivo. Food Front. 2024, 6, 500–515. [Google Scholar] [CrossRef]
  15. Chan, B.C.; Yu, H.; Wong, C.W.; Lui, S.L.; Jolivalt, C.; Ganem-Elbaz, C.; Paris, J.M.; Morleo, B.; Litaudon, M.; Lau, C.B.; et al. Quick identification of kuraridin, a noncytotoxic anti-MRSA (methicillin-resistant Staphylococcus aureus) agent from Sophora flavescens using high-speed counter-current chromatography. J. Chromatogr. B 2012, 880, 157–162. [Google Scholar] [CrossRef]
  16. Liu, Q.Q.; Han, J.; Zuo, G.Y.; Wang, G.C.; Tang, H.S. Potentiation activity of multiple antibacterial agents by Salvianolate from the Chinese medicine Danshen against methicillin-resistant Staphylococcus aureus (MRSA). J. Pharmacol. Sci. 2016, 131, 13–17. [Google Scholar] [CrossRef] [PubMed]
  17. Chan, Y.S.; Chong, K.P. Bioactive Compounds of Ganoderma boninense Inhibited Methicillin-Resistant Staphylococcus aureus Growth by Affecting Their Cell Membrane Permeability and Integrity. Molecules 2022, 27, 838. [Google Scholar] [CrossRef] [PubMed]
  18. Wan, S.J.; Ren, H.G.; Jiang, J.M.; Xu, G.; Xu, Y.; Chen, S.M.; Chen, G.; Zheng, D.; Yuan, M.; Zhang, H.; et al. Two Novel Phenylpropanoid Trimers from Ligusticum chuanxiong Hort with Inhibitory Activities on Alpha-Hemolysin Secreted by Staphylococcus aureus. Front. Chem. 2022, 10, 877469. [Google Scholar] [CrossRef]
  19. Su, T.; Qiu, Y.; Hua, X.; Ye, B.; Luo, H.; Liu, D.; Qu, P.; Qiu, Z. Novel Opportunity to Reverse Antibiotic Resistance: To Explore Traditional Chinese Medicine with Potential Activity Against Antibiotics-Resistance Bacteria. Front. Microbiol. 2020, 11, 610070. [Google Scholar] [CrossRef]
  20. Wang, S.Y.; Sun, Z.L.; Liu, T.; Gibbons, S.; Zhang, W.J.; Qing, M. Flavonoids from Sophora moorcroftiana and their synergistic antibacterial effects on MRSA. Phytother. Res. 2014, 28, 1071–1076. [Google Scholar] [CrossRef]
  21. Li, J.; Feng, S.; Liu, X.; Jia, X.; Qiao, F.; Guo, J.; Deng, S. Effects of Traditional Chinese Medicine and Its Active Ingredients on Drug-Resistant Bacteria. Front. Pharmacol. 2022, 13, 837907. [Google Scholar] [CrossRef]
  22. Kim, G.; Gan, R.Y.; Zhang, D.; Farha, A.K.; Habimana, O.; Mavumengwana, V.; Li, H.B.; Wang, X.H.; Corke, H. Large-Scale Screening of 239 Traditional Chinese Medicinal Plant Extracts for Their Antibacterial Activities against Multidrug-Resistant Staphylococcus aureus and Cytotoxic Activities. Pathogens 2020, 9, 185. [Google Scholar] [CrossRef]
  23. Tierra, M. Planetary Herbology; Lotus Press: Twin Lakes, WI, USA, 2018. [Google Scholar]
  24. Kwok, C.T.; Chow, F.W.; Cheung, K.Y.; Zhang, X.Y.; Mok, D.K.; Kwan, Y.W.; Chan, G.H.; Leung, G.P.; Cheung, K.W.; Lee, S.M.; et al. Medulla Tetrapanacis water extract alleviates inflammation and infection by regulating macrophage polarization through MAPK signaling pathway. Inflammopharmacology 2024, 32, 393–404. [Google Scholar] [CrossRef] [PubMed]
  25. Chen, R.; Li, Y.; Dong, H.; Liu, Z.; Li, S.; Yang, S.; Li, X. Optimization of ultrasonic extraction process of polysaccharides from Ornithogalum Caudatum Ait and evaluation of its biological activities. Ultrason. Sonochem. 2012, 19, 1160–1168. [Google Scholar] [CrossRef] [PubMed]
  26. Jiang, C.; Li, X.; Jiao, Y.; Jiang, D.; Zhang, L.; Fan, B.; Zhang, Q. Optimization for ultrasound-assisted extraction of polysaccharides with antioxidant activity in vitro from the aerial root of Ficus microcarpa. Carbohydr. Polym. 2014, 110, 10–17. [Google Scholar] [CrossRef]
  27. Chemat, F.; Rombaut, N.; Sicaire, A.G.; Meullemiestre, A.; Fabiano-Tixier, A.S.; Abert-Vian, M. Ultrasound assisted extraction of food and natural products. Mechanisms, techniques, combinations, protocols and applications. A review. Ultrason. Sonochemistry 2017, 34, 540–560. [Google Scholar] [CrossRef]
  28. Tam, E.W.T.; Cheung, Y.C.; Lung, W.C.H.; Hui, C.C.; Lam, W.W.; Ng, S.S.M.; Chow, F.W.N. Modulating ultrasound-assisted extraction of polysaccharide-protein complexes from β-glucan-rich medicinal mushrooms for enhanced antioxidant activity. Carbohydr. Polym. Technol. Appl. 2025, 10, 100817. [Google Scholar] [CrossRef]
  29. Cheung, Y.C.; Siu, K.C.; Liu, Y.S.; Wu, J.Y. Molecular properties and antioxidant activities of polysaccharide–protein complexes from selected mushrooms by ultrasound-assisted extraction. Process Biochem. 2012, 47, 892–895. [Google Scholar] [CrossRef]
  30. Cheung, Y.C.; Wu, J.Y. Kinetic models and process parameters for ultrasound assisted extraction of water-soluble components and polysaccharides from a medicinal fungus. Biochem. Eng. J. 2013, 79, 214–220. [Google Scholar] [CrossRef]
  31. Bush, K.; Jacoby, G.A.; Medeiros, A.A. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 1995, 39, 1211–1233. [Google Scholar] [CrossRef]
  32. Almansour, A.M.; Alhadlaq, M.A.; Alzahrani, K.O.; Mukhtar, L.E.; Alharbi, A.L.; Alajel, S.M. The Silent Threat: Antimicrobial-Resistant Pathogens in Food-Producing Animals and Their Impact on Public Health. Microorganisms 2023, 11, 2127. [Google Scholar] [CrossRef]
  33. Liu, Y.; Chen, X.; Luifu, J.; Zhao, J.; He, X.; Xie, T. Extended-spectrum β-lactamase-producing Enterobacteriaceae from ready-to-eat foods: Genetic diversity and antibiotic susceptibility. Food Sci. Nutr. 2023, 11, 5565–5572. [Google Scholar] [CrossRef]
  34. Pervaiz, R.; Bano, S.; Tunio, S.A.; Abro, R.; Abbasi, S. Antibiotic resistance in foodborne pathogens: Implications for the one health approach in developing nations. Microb. Pathog. 2025, 206, 107737. [Google Scholar] [CrossRef] [PubMed]
  35. Cowan, M.M. Plant products as antimicrobial agents. Clin. Microbiol. Rev. 1999, 12, 564–582. [Google Scholar] [CrossRef] [PubMed]
  36. Patel, K.; Patel, D.K. Medicinal importance, pharmacological activities, and analytical aspects of hispidulin: A concise report. J. Tradit. Complement. Med. 2016, 7, 360–366. [Google Scholar] [CrossRef]
  37. Sharifi-Rad, J.; Mnayer, D.; Roointan, A.; Shahri, F.; Ayatollahi, S.A.; Sharifi-Rad, M.; Molaee, N.; Sharifi-Rad, M. Antibacterial activities of essential oils from Iranian medicinal plants on extended-spectrum β-lactamase-producing Escherichia coli. Cell. Mol. Biol. 2016, 62, 75–82. [Google Scholar]
  38. Marrelli, M. Medicinal Plants. Plants 2021, 10, 1355. [Google Scholar] [CrossRef]
  39. Millar, B.C.; Rao, J.R.; Moore, J.E. Fighting antimicrobial resistance (AMR): Chinese herbal medicine as a source of novel antimicrobials—An update. Lett. Appl. Microbiol. 2021, 73, 400–407. [Google Scholar] [CrossRef]
  40. Qadri, H.; Haseeb Shah, A.; Mudasir Ahmad, S.; Alshehri, B.; Almilaibary, A.; Ahmad Mir, M. Natural products and their semi-synthetic derivatives against antimicrobial-resistant human pathogenic bacteria and fungi. Saudi J. Biol. Sci. 2022, 29, 103376. [Google Scholar] [CrossRef] [PubMed]
  41. Hedayat, K.M.; Lapraz, J. The Theory of Endobiogency: Introduction to the Usage of Medicinal Plants; Elsevier, Academic Press: Amsterdam, The Netherlands, 2019; pp. 255–266. [Google Scholar]
  42. Li, S.; Wu, D.; Lv, G.; Zhao, J. Carbohydrates analysis in herbal glycomics. TrAC Trends Anal. Chem. 2013, 52, 155–169. [Google Scholar] [CrossRef]
  43. Xu, W.; Zhao, J.; Li, S. Action mechanisms of polysaccharides in Chinese herbal decoctions. Acupunct. Herb. Med. 2025, 5, 1–22. [Google Scholar] [CrossRef]
  44. European Directorate for the Quality of Medicines & Healthcare; European Pharmacopoeia Commission; Council of Europe. European Pharmacopoeia, 7th ed.; Council of Europe: Strasbourg, France, 2010. [Google Scholar]
  45. Sasidharan, S.; Chen, Y.; Saravanan, D.; Sundram, K.M.; Yoga Latha, L. Extraction, isolation and characterization of bioactive compounds from plants’ extracts. Afr. J. Tradit. Complement. Altern. Med. 2011, 8, 1–10. [Google Scholar] [CrossRef]
  46. Hudz, N.; Makowicz, E.; Shanaida, M.; Białoń, M.; Jasicka-Misiak, I.; Yezerska, O.; Svydenko, L.; Wieczorek, P.P. Phytochemical Evaluation of Tinctures and Essential Oil Obtained from Satureja montana Herb. Molecules 2020, 25, 4763. [Google Scholar] [CrossRef] [PubMed]
  47. Bisht, A.; Sahu, S.C.; Kumar, A.; Maqsood, S.; Barwant, M.M.; Jaiswal, S.G. Recent advances in conventional and innovative extraction techniques for recovery of high-added value compounds for food additives and nutraceuticals. Food Phys. 2025, 2, 100047. [Google Scholar] [CrossRef]
  48. Song, Y.; Ding, Q.; Hao, Y.; Cui, B.; Ding, C.; Gao, F. Pharmacological Effects of Shikonin and Its Potential in Skin Repair: A Review. Molecules 2023, 28, 7950. [Google Scholar] [CrossRef]
  49. Wang, P.; Li, R.J.; Liu, R.H.; Jian, K.L.; Yang, M.H.; Yang, L.; Kong, L.Y.; Luo, J. Sarglaperoxides A and B, Sesquiterpene-Normonoterpene Conjugates with a Peroxide Bridge from the Seeds of Sarcandra glabra. Org. Lett. 2016, 18, 832–835. [Google Scholar] [CrossRef] [PubMed]
  50. Nunes, S.; Madureira, A.R.; Campos, D.; Sarmento, B.; Gomes, A.M.; Pintado, M.; Reis, F. Therapeutic and nutraceutical potential of rosmarinic acid—Cytoprotective properties and pharmacokinetic profile. Crit. Rev. Food Sci. Nutr. 2017, 57, 1799–1806. [Google Scholar] [CrossRef]
  51. Cho, J.; Hong, E.B.; Kim, Y.S.; Song, J.; Ju, Y.H.; Kim, H.; Lee, H.; Kim, H.; Nam, M.H. Baicalin and baicalein from Scutellaria baicalensis Georgi alleviate aberrant neuronal suppression mediated by GABA from reactive astrocytes. CNS Neurosci. Ther. 2024, 30, e14740. [Google Scholar] [CrossRef]
  52. Wu, J.; Qiu, Y.; Tian, M.; Wang, L.; Gao, K.; Yang, X.; Jiang, Z. Flavonoids from Scutellaria baicalensis: Promising Alternatives for Enhancing Swine Production and Health. Int. J. Mol. Sci. 2025, 26, 3703. [Google Scholar] [CrossRef] [PubMed]
  53. Chu, M.; Zhang, M.B.; Liu, Y.C.; Kang, J.R.; Chu, Z.Y.; Yin, K.L.; Ding, L.Y.; Ding, R.; Xiao, R.X.; Yin, Y.N.; et al. Role of Berberine in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections. Sci. Rep. 2016, 6, 24748. [Google Scholar] [CrossRef]
  54. Pan, J.; Wang, H.; Chen, Y. Prunella vulgaris L.—A Review of its Ethnopharmacology, Phytochemistry, Quality Control and Pharmacological Effects. Front. Pharmacol. 2022, 13, 903171. [Google Scholar] [CrossRef]
  55. Sun, J.; Xie, Y.; Chen, Z.; Fan, Y.; Liu, Y.; Gao, Q.; Li, J.; Bai, J.; Yang, Y. Antimicrobial activity and mechanism of Magnolia officinalis root extract against methicillin-resistant Staphylococcus aureus based on mannose transporter. Ind. Crops Prod. 2023, 201, 116953. [Google Scholar] [CrossRef]
  56. Tang, J.; Feng, Y.; Tsao, S.; Wang, N.; Curtain, R.; Wang, Y. Berberine and Coptidis rhizoma as novel antineoplastic agents: A review of traditional use and biomedical investigations. J. Ethnopharmacol. 2009, 126, 5–17. [Google Scholar] [CrossRef]
  57. Amin, A.H.; Subbaiah, T.V.; Abbasi, K.M. Berberine sulfate: Antimicrobial activity, bioassay, and mode of action. Can. J. Microbiol. 1969, 15, 1067–1076. [Google Scholar] [CrossRef]
  58. Hayashi, K.; Minoda, K.; Nagaoka, Y.; Hayashi, T.; Uesato, S. Antiviral activity of berberine and related compounds against human cytomegalovirus. Bioorganic Med. Chem. Lett. 2007, 17, 1562–1564. [Google Scholar] [CrossRef]
  59. Kwok, C.T.; Yu, R.C.; Hau, P.T.; Cheung, K.Y.; Ng, I.C.; Fung, J.; Wong, I.T.; Yau, M.C.; Liu, W.M.; Kong, H.K.; et al. Characteristics and pathogenicity of Vibrio alginolyticus SWS causing high mortality in mud crab (Scylla serrata) aquaculture in Hong Kong. Front. Cell Infect. Microbiol. 2024, 14, 1425104. [Google Scholar] [CrossRef]
  60. Clinical Laboratory Standards Institute (CLSI). M100 Performance Standards for Antimicrobial Susceptibility Testing, 35th ed.; CLSI document M100Ed35E; CLSI: Wayne, PA, USA, 2025. [Google Scholar]
  61. Magiorakos, A.P.; Srinivasan, A.; Carey, R.B.; Carmeli, Y.; Falagas, M.E.; Giske, C.G.; Harbarth, S.; Hindler, J.F.; Kahlmeter, G.; Olsson-Liljequist, B.; et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 2012, 18, 268–281. [Google Scholar] [CrossRef]
  62. School of Chinese Medicine, Hong Kong Baptist University. Medicinal Plant Images Database. 2025. Available online: https://sys01.lib.hkbu.edu.hk/cmed/mpid/index.php (accessed on 4 October 2025).
  63. Chassagne, F.; Huang, X.; Lyles, J.T.; Quave, C.L. Validation of a 16th Century Traditional Chinese Medicine Use of Ginkgo biloba as a Topical Antimicrobial. Front. Microbiol. 2019, 10, 775. [Google Scholar] [CrossRef]
  64. Sheng, Z.; Wang, Y.; Wan, P.; Li, Y. Ultrasound-assisted extraction of total flavonoids from leaves of Syringa Oblata Lindl. Lat. Am. Appl. Res. 2014, 44, 131–135. [Google Scholar] [CrossRef]
  65. European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution. Clin. Microbiol. Infect. 2000, 6, 509–515. [Google Scholar] [CrossRef] [PubMed]
  66. Yang, Y.; Peng, J.; Li, F.; Liu, X.; Deng, M.; Wu, H. Determination of Alkaloid Contents in Various Tissues of Coptis Chinensis Franch. by Reversed Phase-High Performance Liquid Chromatography and Ultraviolet Spectrophotometry. J. Chromatogr. Sci. 2017, 55, 556–563. [Google Scholar] [CrossRef]
Molecules 30 04331 g001
Figure 1. The chromatographic peaks of seven alkaloid compounds from Coptis chinensis Franch. extracted by (a) water decoction; (b) 80% ethanol maceration; and (c) 50% ethanol with ultrasound assisted extraction. (Peaks 1–7 are berberine, palmatine, coptisine, epiberberine, jatrorrhizine, columbamine, and groenlandicine, respectively).
Figure 1. The chromatographic peaks of seven alkaloid compounds from Coptis chinensis Franch. extracted by (a) water decoction; (b) 80% ethanol maceration; and (c) 50% ethanol with ultrasound assisted extraction. (Peaks 1–7 are berberine, palmatine, coptisine, epiberberine, jatrorrhizine, columbamine, and groenlandicine, respectively).
Molecules 30 04331 g001
Molecules 30 04331 g002
Figure 2. The molecular structures of the seven most abundant alkaloids identified from Coptis chinensis Franch. Extracts.
Figure 2. The molecular structures of the seven most abundant alkaloids identified from Coptis chinensis Franch. Extracts.
Molecules 30 04331 g002
Table 1. The fourteen ESBL-PE strains used in this study.
Table 1. The fourteen ESBL-PE strains used in this study.
IsolateSpeciesSourceDate of CollectionFood Origin
B1Escherichia coliPorkAugust 2022China
B2Escherichia coliChickenApril 2022Thailand
B3Escherichia coliBeefAugust 2022China
B4Klebsiella pneumoniaeBeefAugust 2022China
B5Klebsiella pneumoniaePorkMay 2022China
B6Klebsiella pneumoniaeBeefJune 2022China
B7Klebsiella pneumoniaeBeefJuly 2022China
B8Hafnia alveiBeefAugust 2022USA
B9Hafnia alveiPorkJune 2022Spain
B10Citrobacter freundiiSashimiMay 2022Norway
B11Citrobacter freundiiVegetableJune 2022Japan
B12Citrobacter braakiiSashimiAugust 2022Vietnam
B13Proteus hauseriChickenMay 2022China
B14Enterobacter cloacaeVegetableJune 2022Japan
Table 2. Antibiogram of ESBL-PE strains.
Table 2. Antibiogram of ESBL-PE strains.
IsolateSpeciesBeta-Lactamase Resistant GeneEfflux GeneAntibiogram
AMPFEPCTXFOXCAZCROCCIPCSCNIPMMEMNATESXTDOR
B1E. coliblaCTX-M-14, blaEC, blaSHV, blaTEMacrF, emrD, mdtM, silARSDDRSRRRRIRSSSRRS
B2E. coliblaEC, blaCTX-M-1acrF, emrD, mdtMRRRSSRSSRSSSSRSS
B3E. coliblaCTX-M-14, blaEC, blaTEMacrF, emrD, mdtM, silARSDDRSSRRIISSSIRRS
B4K. pneumoniaeblaCTX-M-3, blaSHV, blaTEMemrD, kdeA, oqxA10, oqxB5, silARRRSSRRRIRSSSRRS
B5K. pneumoniaeblaCTX-M-15, blaSHVemrD, kdeA, oqxA, oqxB, silARSDDRSIRSRRSSSSSSS
B6K. pneumoniaeblaCTX-M-65, blaOXA-10, blaSHV, blaTEMemrD, kdeA, arsB, oqxA10, oqxB, silARSDDRSSRRIISSSSRRS
B7K.pneumoniaeblaCTX-M-3, blaSHV, blaTEMemrD, kdeA, oqxA, oqxB19, arsB, silARRRSSRRRRSSSSRRS
B8H. alveiblaACCN/ARSRRRRSSRSSSRSSS
B9H. alveiblaACCN/ARSRSRRSSRSSSRSSS
B10C. freundiiblaCMYarsA, arsBRSRRRRSRRSSSSSSS
B11C. freundiiblaCMYarsA, arsBRSDDRRRRSRISISRSSS
B12C. braakiiblaCMY, blaCTX-M-15N/ARRRRRRSRRSSSSSSS
B13P. hauseriblaDHA, hugAN/ARSRRRSRRRIISSRRS
B14E. cloacaeblaACToqxA, oqxBRSRRRRSRRSSSSSSS
AMP: ampicillin; FEP: cefepime; CTX: cefotaxime; FOX: cefoxitin; CAZ: ceftazidime; CRO: ceftriaxone; C: chloramphenicol; CIP: ciprofloxacin; CS: colistin; CN: gentamicin; IPM: imipenem; MEM: meropenem; NA: nalidixic acid; TE: tetracycline; SXT: co-trimoxazole; DOR: doripenem; S: susceptible; I: intermediate; R: resistant; SDD: susceptible-dose dependent.
Table 3. Six Chinese medicinal herb extracts that demonstrated broad-spectrum anti-ESBL-PE activities against 14 different ESBL-PE strains, as determined by the disc diffusion tests.
Table 3. Six Chinese medicinal herb extracts that demonstrated broad-spectrum anti-ESBL-PE activities against 14 different ESBL-PE strains, as determined by the disc diffusion tests.
HerbExtractionZone of Inhibition (Mean ± S.D., mm)
ESBL-PE Strains
B1B2B3B4B5B6B7B8B9B10B11B12B13B14
L. erythrorhizonW-----11.35 ± 0.37-8.12 ± 0.338.20 ± 0.158.97 ± 0.217.29 ± 0.048.54 ± 0.479.49 ± 0.09-
E-----8.50 ± 0.16---6.54 ± 0.25-6.93 ± 0.077.78 ± 0.16-
UAE-----9.69 ± 0.34-6.76 ± 0.066.80 ± 0.097.31 ± 0.34-7.73 ± 0.138.53 ± 0.14-
S. glabraW-----10.37 ± 0.18-9.33 ± 0.048.13 ± 0.596.79 ± 0.11-7.36 ± 0.0910.07 ± 0.05-
E-----7.79 ± 0.15--------
UAE-----8.43 ± 0.06------7.10 ± 0.09-
S. baicalensisW-----12.06 ± 0.03-9.74 ± 0.428.81 ± 0.058.85 ± 0.21-7.78 ± 0.107.73 ± 0.06-
E-----10.79 ± 0.06-9.48 ± 0.078.47 ± 0.237.59 ± 0.17-8.01 ± 0.157.06 ± 0.13-
UAE-----11.37 ± 0.24-9.68 ± 0.018.63 ± 0.118.15 ± 0.11-8.43 ± 0.037.40 ± 0.16-
C. chinensisW-----12.81 ± 0.22-10.37 ± 0.2010.10 ± 0.176.82 ± 0.15--11.09 ± 0.08-
E9.69 ± 0.5510.54 ± 0.1810.68 ± 0.27--11.73 ± 0.16-9.86 ± 0.1810.29 ± 0.14---10.44 ± 0.21-
UAE11.17 ± 0.4410.68 ± 0.0511.46 ± 0.21--13.38 ± 0.22-10.12 ± 0.1110.48 ± 0.236.95 ± 0.10--10.98 ± 0.18-
P. vulgarisW-----8.05 ± 0.34---6.67 ± 0.33--7.07 ± 0.19-
E-----9.77 ± 0.10-8.14 ± 0.11-6.81 ± 0.05-6.84 ± 0.098.84 ± 0.08-
UAE-----10.92 ± 0.08-7.95 ± 0.47-7.86 ± 0.177.22 ± 0.157.74 ± 0.329.55 ± 0.18-
M. officinalisW-----11.77 ± 0.03-9.07 ± 0.197.19 ± 0.17--7.04 ± 0.0110.92 ± 0.06-
E-----7.75 ± 0.18------7.95 ± 0.14-
UAE-----8.81 ± 0.03-6.42 ± 0.21----8.85 ± 0.04-
W: water decoction; E: 80% ethanol maceration; UAE: 50% ethanol extraction assisted with ultrasound; B1–B3: Escherichia coli; B4–B7: Klebsiella pneumoniae; B8–B9: Hafnia alvei; B10–B11: Citrobacter freundii; B12: Citrobacter braakii; B13: Proteus hauseri; B14: Enterobacter cloacae; -: no inhibitory activity.
Table 4. Minimum inhibitory concentrations of six Chinese medicinal herb extracts against various types of ESBL-PE strains.
Table 4. Minimum inhibitory concentrations of six Chinese medicinal herb extracts against various types of ESBL-PE strains.
HerbExtractionMinimum Inhibitory Concentration (mg/mL)
ESBL-PE Isolates
E. coli B2K. pneumoniae B6H. alvei B8C. freundii B10C. braakii B12P. hauseri B13
L. erythrorhizonW12.51.56253.1253.1256.251.5625
E2512.56.2512.512.512.5
UAE251.56253.1253.1256.253.125
S. glabraW12.53.1256.253.1256.253.125
E2512.56.2512.52512.5
UAE253.1256.256.2512.53.125
S. baicalensisW12.53.1256.253.1253.1253.125
E12.51.56253.1253.1253.1251.5625
UAE12.51.56253.1253.1253.1251.5625
C. chinensisW3.1251.56253.1253.1253.1253.125
E1.56256.253.1253.1251.56253.125
UAE1.56253.1253.1253.1251.56253.125
P. vulgarisW253.1253.1253.1253.1253.125
E>253.1256.256.2512.53.125
UAE253.1256.253.1253.1253.125
M. officinalisW251.56253.1253.1253.1251.5625
E251.56253.1253.1253.1251.5625
UAE250.781253.1253.1253.1251.5625
W: water decoction; E: 80% ethanol maceration; UAE: 50% ethanol extraction assisted with ultrasound.
Table 5. The quantitative content of seven alkaloids (%) in Coptis chinensis extracts.
Table 5. The quantitative content of seven alkaloids (%) in Coptis chinensis extracts.
Alkaloid CompoundsExtracts of C. chinensis
W (%)E (%)UAE (%)
Berberine17.913.423.5
Palmatine7.65.39.0
Coptisine3.72.45.0
Epiberberine8.65.510.9
Jatrorrhizine2.31.62.8
Columbamine1.41.11.7
Groenlandicine0.90.61.2
Total42.429.954.1
W: water decoction; E: 80% ethanol maceration; UAE: 50% ethanol extraction assisted with ultrasound. The percentage content of alkaloids in the C. chinensis extract was calculated as the percentage of the weight of alkaloids in the C. chinensis extract relative to the total weight of the C. chinensis extract.
Table 6. Minimum inhibitory concentrations of berberine and Coptis chinensis UAE extract on the growth of ESBL-PE strains.
Table 6. Minimum inhibitory concentrations of berberine and Coptis chinensis UAE extract on the growth of ESBL-PE strains.
ESBL-PE StrainsBerberine (mg/mL)C. chinensis with UAE Extract (mg/mL) *Equivalent Berberine Concentration in C. chinensis with UAE Extract (mg/mL)
E. coli B20.751.56250.368
K. pneumoniae B63.003.1250.735
H. alvei B80.753.1250.735
C. freundii B103.003.1250.735
C. braakii B120.751.56250.368
P. hauseri B131.503.1250.735
* C. chinensis UAE extract contains 23.5% berberine.
Table 7. The twenty Chinese medicinal herbs used in this study.
Table 7. The twenty Chinese medicinal herbs used in this study.
Scientific Name and Part of Plant UsedPlace of OriginPharmacology [62]Phytoconstituents [62]
Scleromitrion diffusum (willd) R.J.Wang (Leaves)JiangxiAnti-tumor and anti-inflammatoryAsperuloside, organic acids and their esters, anthraquinones, triterpenes
Houttuynia cordata Thunb. (Whole plant)GuangdongAnti-viral, antibacterial, immunity-strengthening, etc.Volatile oil and flavonoids
Lithospermum erythrorhizon Siebold & Zucc. (Root)XinjiangAnti-inflammatory, anti-pathogenic microorganism, pain-killing, etc.Shikonin, acetylshikonin, deoxyshikonin
Wurfbainia villosa (Lour.) Škorničk. & A.D.Poulsen (Fruit)GuangdongAnti-platelet aggregation, anti-ulcer and pain-relievingBornyl acetate, camphor, and limonene
Scrophularia ningpoensis Hemsl. (Root)HubeiPreserving effects on the cardiovascular system, CNS-inhibiting, etc.Iridoids compounds, ningpogenin, ningpogosides A and B
Portulaca oleracea L. (Whole plant)JiangsuAntibacterial, uterus-contracting, blood-fat-lowering, etc.Noradrenaline, dopa, dopamine, betanidin, oxalic acid, triterpene
Grona styracifolia (Osbeck) H.Ohashi & K.Ohashi. (Whole plant)SichuanAnti-inflammatory, pain-killing, etcAlkaloid, flavone flycosides, phenols, tannin
Lonicera japonica Thunb. (Flower bud)HenanAntimicrobial, anti-inflammatory, antifebrile, blood-fat-lowering, etc.Chlorogenic acid, ginnol, isochlorogenic acid, β-sitosterol, linalool, etc.
Gardenia jasminoides J.Ellis (Fruit)HubeiHepatic-protective, anti-inflammatoryFlavonoid genipin, pectin, and tannin
Atractylodes macrocephala Koidz. (Rhizoma)ZhejiangGastric-ulcer-preventing, intestines-movement-influencing, anti-bacteria, etc.Atratylone, eudesmol, palmitic acid, hinesol, humulene, sesquiterpene lactones, polyynealcohols
Atractylodes lancea (Thunb.) DC. (Rhizoma)ZhejiangGastric-secretion-restraining, influential on the liver, blood sugar and stomach and intestinal movement, etc.Volatile oil, atraclyloin, atractylon, chamigrene, caryophyllene, elemene, atractylodin, furaldehyde, tryptophane, etc.
Sarcandra glabra (Thunb.) Nakai (Whole plant)GuangdongAnti-tumors, antibacterial, antivirotic, etc.Coumarin, flavonoid glycosides, essential oils, tannin
Scutellaria baicalensis Georgi (Root)HebeiAntibacterial, anti-inflammatory, heart-brain-protecting, hepatic-protective, immunity-regulating and anti-tumor and antiallergicBaicalensis and baicalein
Forsythia suspensa (Thunb.) Vahl (Fruit)HebeiAntimicrobial, anti-inflammatory, etc.Lignans, flavonoids, benzene ethane derivatives
Glycyrrhiza uralensis Fisch. (Root)Inner MongoliaAnti-viral, antibacterial, anti-ulcer, atitussive, anti-inflammatory, phlegm-removing, anti-tumor, etc.Triterpenoid saponins
Chrysanthemum morifolium Ramat. (Flower)Hangzhouantibacterial and cardiovascular-system-affectingBorneol, chrysanthenone, camphor, acacetin-7-rhamnoglucoside, indican, thymol, apigenin, luteolin, cosmosiin, volatile oils
Coptis chinensis Franch. (Root)SichuanAntimicrobial, antiprotozoal, beneficial to cyclic system and nervous system, anti-arrhythmia, anti-ulcer, beneficial to the gallbladder, anti-tumor and anti-inflammatoryBerberine, epiberberine, coptisine, berberrubine, palmatine, jatrorrhizine, worenine, magnoflorine, ferulic acid, obakunone, obakulactone
Prunella vulgaris L. (Fruit spike)HenanAnti-hypertension, hyperglycemic, antibacterial, anti-viral, etc.Saponin, ursolic acid, tartaric acid, prunellin
Magnolia officinalis Rehder & E.H.Wilson (Bark)SichuanAnti-ulcerative, anti-pathogenic microorganism and anti-tumors, anti-patelet, etc.Lignan, monoterpene lignin, norlignan, honokiol, camphor
Sophora flavescens Aiton (Root)HenanAnti-inflammatory, anti-pathogenic microorganism, etc.Alkaloids, flavonoids
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Hui, C.C.; Lee, F.W.F.; Lung, W.C.H.; Fan, K.C.; Wong, I.T.F.; Siu, G.K.H.; Chow, Y.L.; Chan, P.L.; Ng, S.-M.; Shi, L.; et al. Ultrasound-Assisted Extraction: Unlocking the Antibacterial Potential of Coptis chinensis Franch. Against ESBL-Producing Enterobacterales. Molecules 2025, 30, 4331. https://doi.org/10.3390/molecules30224331

AMA Style

Hui CC, Lee FWF, Lung WCH, Fan KC, Wong ITF, Siu GKH, Chow YL, Chan PL, Ng S-M, Shi L, et al. Ultrasound-Assisted Extraction: Unlocking the Antibacterial Potential of Coptis chinensis Franch. Against ESBL-Producing Enterobacterales. Molecules. 2025; 30(22):4331. https://doi.org/10.3390/molecules30224331

Chicago/Turabian Style

Hui, Ching Ching, Fred Wang Fat Lee, Wesley Chin Ho Lung, Kai Chung Fan, Ivan Tak Fai Wong, Gilman Kit Hang Siu, Yeuk Lung Chow, Ping Lung Chan, Siu-Mui Ng, Ling Shi, and et al. 2025. "Ultrasound-Assisted Extraction: Unlocking the Antibacterial Potential of Coptis chinensis Franch. Against ESBL-Producing Enterobacterales" Molecules 30, no. 22: 4331. https://doi.org/10.3390/molecules30224331

APA Style

Hui, C. C., Lee, F. W. F., Lung, W. C. H., Fan, K. C., Wong, I. T. F., Siu, G. K. H., Chow, Y. L., Chan, P. L., Ng, S.-M., Shi, L., Seto, S. W., Chow, F. W. N., & Tam, E. W. T. (2025). Ultrasound-Assisted Extraction: Unlocking the Antibacterial Potential of Coptis chinensis Franch. Against ESBL-Producing Enterobacterales. Molecules, 30(22), 4331. https://doi.org/10.3390/molecules30224331

Article Metrics

Back to TopTop